ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors
Clinical trial NCT05276609 · UNKNOWN
Trial details
- NCT number
- NCT05276609
- Sponsor
- Shanghai Hansoh Biomedical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-28
- Primary completion
- 2023-12-31
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.